Financhill
Back

Alnylam Pharmaceuticals, Inc. 10K Form

Sell
43

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$398.51
Seasonality Move:
2.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ALNY News And Ratings

See the #1 stock for the next 7 days that we like better than ALNY

ALNY Financial Statistics

Sales & Book Value

Annual Sales: $2.2B
Cash Flow: $313M
Price / Cash Flow: 237.08
Annual Sales: $1.77
Price / Book: 225.1

Profitability

EPS (TTM): 0.24050
Net Income (TTM): $43.6M
Gross Margin: $1.9B
Return on Equity: 31.15%
Return on Assets: 0.98%

Alnylam Pharmaceuticals, Inc. Earnings Forecast

Key Alnylam Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 20 years for ALNY is 85.62%.
  • The Selling, General & Administrative Expenses for ALNY have been equal to 43.39% of Gross Profit Margin.
  • The Research & Development expenses have been 50.09% of Revenue.
  • The Net Earning history of ALNY is -12.37% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

Alnylam Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALNY
CUSIP: 02043Q
Website: alnylam.com

Debt

Debt-to-Equity Ratio: 11.86
Current Ratio: 2.54
Quick Ratio: 2.37

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 35.64

ALNY Technical Analysis vs Fundamental Analysis

Sell
43
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. a Buy or a Sell?